Zykadia
Term · Oncology and biomedicine · MLC-T-ONC-009504
A drug used to treat adults with non-small cell lung cancer that has spread and is ALK positive. It is also being studied in the treatment of other types of cancer. Zykadia blocks certain proteins made by the ALK gene. Blocking these proteins may stop the growth and spread of cancer cells. Zykadia is a type of tyrosine kinase inhibitor. Also called ceritinib.
| Identifier | MLC-T-ONC-009504 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | ceritinib |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009504",
"term": "Zykadia",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with non-small cell lung cancer that has spread and is ALK positive. It is also being studied in the treatment of other types of cancer. Zykadia blocks certain proteins made by the ALK gene. Blocking these proteins may stop the growth and spread of cancer cells. Zykadia is a type of tyrosine kinase inhibitor. Also called ceritinib.",
"synonyms": [
"ceritinib"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/zykadia/"
}
Record 17,715 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.